JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB247612

Anti-beta Amyloid 1-38 antibody [EPR1878(2)] - BSA and Azide free

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal Amyloid-beta precursor protein antibody. Carrier free. Suitable for sELISA, WB and reacts with Human samples.

View Alternative Names

A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II

2 Images
Sandwich ELISA - Anti-beta Amyloid 1-38 antibody [EPR1878(2)] - BSA and Azide free (AB247612)
  • sELISA

Lab

Sandwich ELISA - Anti-beta Amyloid 1-38 antibody [EPR1878(2)] - BSA and Azide free (AB247612)

This data was developed using ab108253, the same antibody clone in a different buffer formulation.

ELISA of beta Amyloid 1-38 peptide at 2μg/mL. Detected with ab108253 at 0~500 pg/mL. Peroxidase Streptavidin SA-HRP at 1/20000 was used as a secondary antibody.

Washing buffer : 1X PBST
Blocking buffer : 1% BSA/PBS

Western blot - Anti-beta Amyloid 1-38 antibody [EPR1878(2)] - BSA and Azide free (AB247612)
  • WB

Unknown

Western blot - Anti-beta Amyloid 1-38 antibody [EPR1878(2)] - BSA and Azide free (AB247612)

This data was developed using ab108253, the same antibody clone in a different buffer formulation.

All lanes:

Western blot - Anti-beta Amyloid 1-38 antibody [EPR1878(2)] (<a href='/en-us/products/primary-antibodies/beta-amyloid-1-38-antibody-epr18782-ab108253'>ab108253</a>) at 1/1000 dilution

Lane 1:

Abeta38 protein at 10 µg

Lane 2:

Abeta40 protein at 10 µg

Lane 3:

Abeta42 protein at 10 µg

Predicted band size: 86 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR1878(2)

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

WB, sELISA

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody is specific to the cleaved peptide Abeta38.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "sELISA" : {"fullname" : "Sandwich ELISA", "shortname":"sELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "sELISA-species-checked": "testedAndGuaranteed", "sELISA-species-dilution-info": "", "sELISA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>" } } }

Product details

ab247612 is the carrier-free version of ab108253.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Beta Amyloid 1-38 also known as Aβ1-38 is a peptide that originates from the amyloid precursor protein (APP) through proteolytic processing. This peptide has a mass of approximately 4.17 kDa. Aβ1-38 is expressed in the brain and other tissues and it plays a role in the complex network of amyloidogenic processing. Its generation results from the sequential cleavage of APP by beta-secretase and gamma-secretase enzymes where it is one of the shorter forms of amyloid-beta peptides produced.
Biological function summary

Beta amyloid 1-38 participates in amyloid plaque formation which is significant in neurodegenerative processes. This peptide is part of a heterogenous group of amyloid-beta peptides which includes other forms like beta amyloid 1-40 and beta amyloid 1-42. Aβ1-38 contributes to the complex accumulation and aggregation of amyloid fibrils that have implications in synaptic functions and neuronal health. Its interactions influence cell signaling pathways and processes involved in cellular stress responses.

Pathways

Beta amyloid 1-38 plays a role in the amyloidogenesis pathway. This pathway impacts the regulation of synaptic activity and neural communication. The peptide is integrated into pathways connected with mitochondrial function and oxidative stress influencing how neurons react to metabolic demands. Proteins related to this pathway include presenilin which is a component of the gamma-secretase complex responsible for APP processing and tau protein which is involved in microtubule stability within cells.

Beta amyloid 1-38 is important in the pathology of Alzheimer's disease. The peptide's accumulation contributes to the formation of amyloid plaques a hallmark of the disease. Another disorder linked to beta amyloid peptide aggregates is cerebral amyloid angiopathy where the deposition in cerebral vessels can lead to vascular damage. Aβ1-38's relationship with proteins such as tau which forms neurofibrillary tangles in Alzheimer's highlights shared pathogenic mechanisms in these disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed : 25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(o) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapses in axons (PubMed : 17062754, PubMed : 23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1.. Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta protein 42 is a more effective reductant than amyloid-beta protein 40. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. APP42-beta may activate mononuclear phagocytes in the brain and elicit inflammatory responses. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.. Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain.. The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.
See full target information APP

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com